Life Sciences reports "disappointing" first half
This article was originally published in Clinica
Executive Summary
UK-based Life Sciences International has described first-half results as disappointing when compared with "an excellent performance in the previous year". After-tax profit declined 20% to £6.9 million ($11 million) due mainly to exchange rate movements and reorganisation of US distribution.